Mislabeled ReliOn Insulin Syringes Prompt Nationwide Recall
The FDA is notifying health care professionals and patients that Covidien (Tyco Healthcare Group LP) is recalling one lot of ReliOn single-use, disposable, hypodermic syringes (with permanently affixed hypodermic needles) due to possible mislabeling. The use of these syringes may lead patients to receive an overdose of as much as 2.5 times the intended dose, which may cause serious health consequences, such as hypoglycemia and even death.
Consumers and health care professionals who suspect they have the recalled product may also contact Covidien at 866-780-5436 or www.relion.com/recall for more information. A person injured by a defective or dangerous product may be eligible to file a lawsuit for product liability. Damages can be recovered under one of the following categories: strict products liability; negligence or breach of warranty. To learn more, contact a qualified personal injury attorney in your area today.
Topics: attorney, Covidien, damages, dangerous product, death, fda, health, Injured, injury, jury, law, lawsuit, liability damages, Mislabeled, Nationwide, negligence, personal, personal injury, personal injury attorney, products liability, recall